Buy CJC-1295 + Ipamorelin in Canada
Hormonal, Growth Hormone & Body Composition Research
Almost every problem people have buying CJC-1295 comes down to two letters: DAC. There are two different compounds sold under nearly the same name, they behave nothing alike, and plenty of listings never say which one is in the vial. Sort that out first and the rest of the decision is straightforward.
CJC-1295 with DAC vs without DAC
CJC-1295 is a growth hormone releasing hormone (GHRH) analogue. The DAC — Drug Affinity Complex — is an added molecule that binds the peptide to albumin in the bloodstream, and it changes the compound’s behaviour completely.
- With DAC: albumin binding stretches its presence out to something measured in days.
- Without DAC (often listed as Mod GRF 1-29): no albumin binding, and it clears in roughly half an hour.
Those are two genuinely different research materials. A listing that just says “CJC-1295” without specifying is telling you the vendor either does not know or does not think the distinction matters. It does.
Why it is usually paired with ipamorelin
CJC-1295 and ipamorelin act on different receptors. CJC-1295 is a GHRH analogue; ipamorelin is a ghrelin receptor agonist, and a notably selective one. Research pairs them precisely because they are two separate pathways rather than two versions of the same lever — which is why the blend is far more commonly studied than either alone.
Buying it in Canada: the part that actually costs people money
Neither compound is approved for human use in Canada. No pharmacy stocks them, no prescription exists, and everything sold is supplied strictly as a research material for laboratory use. That leaves two routes.
From a US or overseas vendor. The parcel crosses the border, and unapproved compounds are exactly the category the CBSA may hold or seize. Through 2026 community reports have described seizures concentrated at west-coast entry points and group orders lost together. A seized vial is not replaced.
From a supplier already inside Canada. No border, no customs category, no seizure risk — the parcel travels like any domestic delivery. This is why Canadian research buyers have moved so decisively toward domestic supply.
What to check before ordering
- DAC status stated plainly. If the page does not say with or without DAC, you do not know what you are buying.
- The blend ratio and vial size in writing. “CJC-1295 + Ipamorelin” with no quantities is not a specification.
- Dispatch you can verify. Canadian tracking from a Canadian origin, not “ships worldwide.”
- Research-use framing. A supplier making health claims about an unapproved compound is showing you how carefully they operate.
Vistara Labs stocks CJC-1295 + Ipamorelin 10 mg (no DAC) as a lyophilised blend, shipped from within Canada to every province. Payment by Interac e-Transfer; orders over $150 ship free.
Frequently asked questions
Is CJC-1295 the same as Mod GRF 1-29?
Mod GRF 1-29 is the common name for CJC-1295 without DAC. The DAC version is a different compound with a much longer duration.
Can you buy CJC-1295 and ipamorelin in Canada?
As research materials, yes — from Canadian research suppliers, for laboratory use only. Neither is available as a medicine in Canada.
Why are they sold together?
Because they act on different receptors — GHRH and ghrelin — so the blend is what most of the research literature actually examines.
Will an order be stopped at customs?
Only if it ships from outside the country. A domestic order never crosses a border.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.
References
The published human CJC-1295 trial used the long-acting DAC analogue, not the no-DAC form. Ipamorelin has its own human pharmacokinetic study. No trial of the two combined was identified.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsRandomised placebo-controlled trial in healthy adults — of the LONG-ACTING (DAC) CJC-1295 analogue, not the no-DAC form.
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteersHuman pharmacokinetic/pharmacodynamic study; five escalating infusion levels, eight healthy male subjects per level.
Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.
